![]() |
![]() |
Legal status
Patent lapsed (non-payment of fees)
(51) | INT.CL. | A61K 31/7076 | (2006.01) |
A61K 38/21 | (2006.01) | ||
A61P 25/00 | (2006.01) |
(11) | Number of the document | 1827461 |
(13) | Kind of document | T |
(96) | European patent application number | 05823474.1 |
Date of filing the European patent application | 2005-12-20 | |
(97) | Date of publication of the European application | 2007-09-05 |
(45) | Date of publication and mention of the grant of the patent | 2012-02-29 |
(46) | Date of publication of the claims translation | 2012-05-25 |
(86) | Number | PCT/EP2005/056954 |
Date | 2005-12-20 |
(87) | Number | WO 2006/067141 |
Date | 2006-06-29 |
(30) | Number | Date | Country code |
638669 P | 2004-12-22 | US | |
04106909 | 2004-12-22 | EP |
(72) |
DE LUCA, Giampiero, CH
YTHIER, Arnaud, CH
MUNAFO, Alain, CH
LOPEZ-BRESNAHAN, Maria, US
|
(73) |
Merck Serono SA,
Centre Industriel, 1267 Coinsins, Vaud,
CH
|
(74) |
Marius JAKULIS - JASON,
AAA Law, A. Goštauto g. 40B, Verslo centras "Dvyniai", LT-03163 Vilnius,
LT
|
(54) | Kladribino vartojimo schema, gydant dauginę sklerozę |
CLADRIBINE REGIMEN FOR TREATING MULTIPLE SCLEROSIS |
Payment date | Validity (years) | Amount | |
2013-11-20 | 9 | 720.00 LTL |
Patent lapsed (non-payment of fees) | ||
Invalidation date | 2014-12-20 |